You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Medicated Skin Care in Peru

Jul 2011

Price: $900

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Peru with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Peru, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Peru market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Peru?
  • What are the major brands in Peru?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

TRENDS

  • According to Euromonitor International estimates, in 2010 per capita spending on medicated skin care products in Peru was the third lowest in the wider Latin American region. This was reflective of the high prices of medicated skin care products and the fact that generics and private label products are not present in the category. As a result, demand is restricted to a relatively small base of high and middle income consumers.

COMPETITIVE LANDSCAPE

  • Domestic company Farmindustria led medicated skin care in 2010, claiming a value share of 15%. The company’s leadership was mainly due to the popularity of its antiparasitics/lice treatments brand Nopucid, but it also offered the haemorrhoid treatments brand Hemorrodil. Farmindustria has a longstanding presence in Peru, and its products are widely trusted by local consumers. Multinational Bayer was the second leading player overall, claiming a value share of 14% thanks to the combined strength of its Canesten (topical antifungals) and Gynocanesten (vaginal antifungals) brands, which led their respective categories. Canesten in particular is heavily advertised, and is widely perceived as a high quality brand that delivers effective results. Medifarma, another domestic company, was the third leading medicated skin care player, claiming a value share of 13% with its topical germicidals/antiseptics brand Isodine. Isodine has an excellent reputation for quality among Peruvian consumers, and is also favoured for its affordable price. Other prominent medicated skin care players in 2010 included GlaxoSmithKline, Productos Avon, Corporación Infarmasa SA, Farmacéutico Peruano SRL and Laboratorios AC Farma SA.

PROSPECTS

  • Medicated skin care looks set to maintain its positive development over the forecast period. Total constant value sales are expected to grow at a CAGR of 2%, and healthy growth in volume terms is predicted for all product categories. Economic improvements will play a key role in boosting volume and constant value sales, with the Central Bank of Peru predicting that real GDP growth will reach 6% over 2011-2012. Rising disposable incomes will enable new consumers to enter the wider medicated skin care category, and encourage existing users to buy products more frequently or trade up to more expensive brands. Peru’s humid climate will also help to sustain demand for medicated skin care products, as high humidity causes many consumers to experience various conditions that cause skin irritation. New launches, improvements in distribution and advertising campaigns by leading manufacturers will also contribute to growth in volume and constant value sales.

Table of Contents

Table of Contents

Medicated Skin Care in Peru - Category Analysis

HEADLINES

TRENDS

  • According to Euromonitor International estimates, in 2010 per capita spending on medicated skin care products in Peru was the third lowest in the wider Latin American region. This was reflective of the high prices of medicated skin care products and the fact that generics and private label products are not present in the category. As a result, demand is restricted to a relatively small base of high and middle income consumers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic company Farmindustria led medicated skin care in 2010, claiming a value share of 15%. The company’s leadership was mainly due to the popularity of its antiparasitics/lice treatments brand Nopucid, but it also offered the haemorrhoid treatments brand Hemorrodil. Farmindustria has a longstanding presence in Peru, and its products are widely trusted by local consumers. Multinational Bayer was the second leading player overall, claiming a value share of 14% thanks to the combined strength of its Canesten (topical antifungals) and Gynocanesten (vaginal antifungals) brands, which led their respective categories. Canesten in particular is heavily advertised, and is widely perceived as a high quality brand that delivers effective results. Medifarma, another domestic company, was the third leading medicated skin care player, claiming a value share of 13% with its topical germicidals/antiseptics brand Isodine. Isodine has an excellent reputation for quality among Peruvian consumers, and is also favoured for its affordable price. Other prominent medicated skin care players in 2010 included GlaxoSmithKline, Productos Avon, Corporación Infarmasa SA, Farmacéutico Peruano SRL and Laboratorios AC Farma SA.

PROSPECTS

  • Medicated skin care looks set to maintain its positive development over the forecast period. Total constant value sales are expected to grow at a CAGR of 2%, and healthy growth in volume terms is predicted for all product categories. Economic improvements will play a key role in boosting volume and constant value sales, with the Central Bank of Peru predicting that real GDP growth will reach 6% over 2011-2012. Rising disposable incomes will enable new consumers to enter the wider medicated skin care category, and encourage existing users to buy products more frequently or trade up to more expensive brands. Peru’s humid climate will also help to sustain demand for medicated skin care products, as high humidity causes many consumers to experience various conditions that cause skin irritation. New launches, improvements in distribution and advertising campaigns by leading manufacturers will also contribute to growth in volume and constant value sales.

CATEGORY DATA

  • Table 1 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 3 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 4 Medicated Skin Care Brand Shares 2007-2010
  • Table 5 Hair Loss Treatments Brand Shares 2007-2010
  • Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Medicated Skin Care in Peru - Company Profiles

Corporación Infarmasa SA in Consumer Health (Peru)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Corporación Infarmasa SA: Competitive Position 2010

Farmindustria SA in Consumer Health (Peru)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Farmindustria SA: Competitive Position 2010

Medifarma SA in Consumer Health (Peru)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Medifarma SA: Competitive Position 2010

Consumer Health in Peru - Industry Context

EXECUTIVE SUMMARY

Economic recovery and rising health awareness bolster market performance

Herbal/traditional products find favour with middle and high income earners

Market penetration of private label products continues to rise

Parapharmacies/drugstores remains the dominant distribution channel

Market outlook for 2010-2015 remains favourable

KEY TRENDS AND DEVELOPMENTS

Economic recovery underpins positive market performance in 2010

Illegal products remain a major problem in the consumer health market

Herbal/traditional products continue to gain popularity in Peru

MARKET INDICATORS

  • Table 8 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 9 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 10 Sales of Consumer Health by Category: Value 2005-2010
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 12 Consumer Health Company Shares 2006-2010
  • Table 13 Consumer Health Brand Shares 2007-2010
  • Table 14 Penetration of Private Label by Category 2005-2010
  • Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 17 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

De-Listing or De-Reimbursement

Pharmaceutical Registration

Patent Protection and Intellectual Property Rights

Combination Products

Advertising

Packaging

Labelling

Vitamins and Dietary Supplements: Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Consumer Trends

Combination Products

Advertising

Retail Distribution

Self-medication/Self-care and Preventative Medicine

Switches

DEFINITIONS

  • Summary 10 Research Sources

Segmentation

Segmentation

This market research report includes the following:

  • Medicated Skin Care
    • Acne Treatments
    • Medicated Shampoos
    • Topical Antifungals
    • Vaginal Antifungals
    • Hair Loss Treatments
    • Nappy (Diaper) Rash Treatments
    • Antiparasitics/Lice (Head and Body) Treatments
    • Antipruritics
    • Child-Specific Medicated Skin Care
    • Cold Sore Treatments
    • Haemorrhoid Treatments
    • Topical Allergy Remedies/Antihistamines
    • Topical Germicidals/Antiseptics

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Consumer Lifestyle

Future Demographic

Country Report